CC
Callan Capital Portfolio holdings
AUM
$1.35B
1-Year Return
8.35%
This Quarter Return
+2.13%
1 Year Return
+8.35%
3 Year Return
+20.11%
5 Year Return
+98.58%
10 Year Return
+94.69%
AUM
$1.21B
AUM Growth
+$77.3M
(+6.8%)
Cap. Flow
+$64.9M
Cap. Flow
% of AUM
5.34%
Top 10 Holdings %
Top 10 Hldgs %
46.34%
Holding
331
New
34
Increased
189
Reduced
69
Closed
18
Top Buys
| 1 |
NVIDIA
NVDA
|
$22.5M |
| 2 |
Neumora Therapeutics
NMRA
|
$4.48M |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
$3.81M |
| 4 |
Avantis US Small Cap Value ETF
AVUV
|
$3.64M |
| 5 |
iShares S&P 500 Growth ETF
IVW
|
$3.54M |
Top Sells
Sector Composition
| 1 | Technology | 7.76% |
| 2 | Healthcare | 2.78% |
| 3 | Financials | 1.79% |
| 4 | Communication Services | 1.44% |
| 5 | Consumer Discretionary | 1.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Royal Bank of Canada
RY
$204B
| $371K | 0.03% |
3,490
+706
| +25% | +$75.1K |
|
202
Target
TGT
$42.3B
| $368K | 0.03% |
2,483
-31
| -1% | -$4.59K |
|
203
Royal Caribbean
RCL
$95.7B
| $366K | 0.03% |
2,298
+48
| +2% | +$7.65K |
|
204
Eaton
ETN
$136B
| $366K | 0.03% |
+1,167
| New | +$366K |
|
205
Unilever
UL
$158B
| $365K | 0.03% |
6,640
+1,215
| +22% | +$66.8K |
|
206
Gilead Sciences
GILD
$143B
| $364K | 0.03% |
5,299
+608
| +13% | +$41.7K |
|
207
Vodafone
VOD
$28.5B
| $362K | 0.03% |
40,768
+6,712
| +20% | +$59.5K |
|
208
Schwab US REIT ETF
SCHH
$8.38B
| $361K | 0.03% |
18,100
-16
| -0.1% | -$320 |
|
209
iShares US Equity Factor ETF
LRGF
$2.84B
| $360K | 0.03% |
6,473
+2
| +0% | +$111 |
|
210
iShares Core MSCI Emerging Markets ETF
IEMG
$103B
| $360K | 0.03% |
6,722
-205
| -3% | -$11K |
|
211
L3Harris
LHX
$51B
| $358K | 0.03% |
1,595
+602
| +61% | +$135K |
|
212
Banco Santander
SAN
$141B
| $354K | 0.03% |
76,556
+24,048
| +46% | +$111K |
|
213
O'Reilly Automotive
ORLY
$89B
| $353K | 0.03% |
5,010
+15
| +0.3% | +$1.06K |
|
214
Brookfield
BN
$99.5B
| $347K | 0.03% |
8,356
+3,240
| +63% | +$135K |
|
215
Wells Fargo
WFC
$253B
| $345K | 0.03% |
5,804
+342
| +6% | +$20.3K |
|
216
Regeneron Pharmaceuticals
REGN
$60.8B
| $341K | 0.03% |
324
+21
| +7% | +$22.1K |
|
217
AT&T
T
$212B
| $340K | 0.03% |
17,805
+4,268
| +32% | +$81.6K |
|
218
Philip Morris
PM
$251B
| $340K | 0.03% |
3,358
+285
| +9% | +$28.9K |
|
219
Citigroup
C
$176B
| $333K | 0.03% |
5,241
+431
| +9% | +$27.4K |
|
220
Arrow Electronics
ARW
$6.57B
| $331K | 0.03% |
2,745
+782
| +40% | +$94.4K |
|
221
Shopify
SHOP
$191B
| $331K | 0.03% |
5,015
+114
| +2% | +$7.53K |
|
222
IBM
IBM
$232B
| $326K | 0.03% |
1,887
+567
| +43% | +$98.1K |
|
|
ORAN
223
DELISTED
Orange
ORAN
| $324K | 0.03% |
32,393
+18,034
| +126% | +$180K |
|
224
Sony
SONY
$165B
| $323K | 0.03% |
18,985
-3,185
| -14% | -$54.1K |
|
225
RELX
RELX
$85.9B
| $320K | 0.03% |
6,967
+659
| +10% | +$30.2K |
|